 Platelet factor PAF tumor necrosis factor-alpha TNF interactions endotoxemic shock studies BN novel PAF antagonist BN new PAF receptor antagonist vitro vivo capacity PAF endotoxin recombinant human tumor necrosis factor-alpha rTNF effects vitro BN PAF-induced platelet aggregation conscious rat pretreatment min BN attenuated PAF-induced hypotension mm Hg recovery time mean arterial pressure sec mg/kg endotoxin mg/kg induced-hemoconcentration reduced mortality partial protection BN hypotensive response mm Hg BN lipopolysaccharide-induced elevation plasma thromboxane microliters tumor necrosis factor-alpha U/ml whereas leukopenia thrombocytopenia unchanged